Show simple item record

dc.contributor.authorHjemdal, Odin
dc.contributor.authorSolem, Stian
dc.contributor.authorHagen, Roger
dc.contributor.authorKennair, Leif Edward Ottesen
dc.contributor.authorNordahl, Hans Morten
dc.contributor.authorWells, Adrian
dc.date.accessioned2019-08-26T08:41:48Z
dc.date.available2019-08-26T08:41:48Z
dc.date.created2019-08-15T13:36:15Z
dc.date.issued2019
dc.identifier.citationFrontiers in Psychology. 2019nb_NO
dc.identifier.issn1664-1078
dc.identifier.urihttp://hdl.handle.net/11250/2610941
dc.description.abstractThis paper reports the 1-year follow-up results from a randomized controlled trial (RCT), which examined the efficacy of metacognitive therapy (MCT) for unipolar depression compared to a waiting condition. Thirty-nine patients with major depression were offered MCT and were divided into two conditions; immediate MCT with 10 weekly sessions or a waiting period that had a 10-week delayed MCT start. Two participants dropped out during the waiting condition. Thirty-four patients participated in the follow-up assessment. Based on the intent-to-treat sample and all patients, 67% were classified as recovered, 13% improved, and 20% were unchanged at 1-year follow-up. For the completers sample 73% recovered, 12% improved, and 15% were unchanged. Five of the 31 patients (13%) that were in remission at post-treatment experienced relapse at 1-year follow-up. Within-group effect sizes were large for reductions in symptoms of depression (d = 2.09) and anxiety (d = 1.16) at 1-year. Treatment response was associated with reductions in rumination, worry, and metacognitive beliefs as predicted by the metacognitive model, but reductions in metacognitions independently predicted reductions in depression scores from pre-treatment to 1-year follow-up. The results suggest that treatment gains are stable at 1-year follow-up. The study sets the stage for future research, which should evaluate MCT over a longer term and compare it with active treatments using suitably powered RCTs.nb_NO
dc.language.isoengnb_NO
dc.publisherFrontiers Medianb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleA Randomized Controlled Trial of Metacognitive Therapy for Depression: Analysis of 1-Year Follow-Upnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.journalFrontiers in Psychologynb_NO
dc.identifier.doi10.3389/fpsyg.2019.01842
dc.identifier.cristin1716168
dc.description.localcodeCopyright © 2019 Hjemdal, Solem, Hagen, Kennair, Nordahl and Wells. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.nb_NO
cristin.unitcode194,67,40,0
cristin.unitcode194,65,35,0
cristin.unitcode1920,22,0,0
cristin.unitnameInstitutt for psykologi
cristin.unitnameInstitutt for psykisk helse
cristin.unitnamePH - Nidaros distriktspsykiatriske senter
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal